Development
Dolby Laboratories, Inc.
DLB
$72.56
$0.580.81%
NYSE
| 12/29/2023 | 09/29/2023 | 06/30/2023 | 03/31/2023 | 12/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -5.78% | 4.44% | 3.03% | 12.42% | -4.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.78% | 4.44% | 3.03% | 12.42% | -4.75% |
| Cost of Revenue | -6.94% | -4.38% | 15.46% | 15.58% | 5.32% |
| Gross Profit | -5.64% | 5.80% | 1.27% | 12.04% | -5.79% |
| SG&A Expenses | 1.40% | 9.52% | 7.29% | -13.81% | -10.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.91% | 8.41% | 9.02% | -6.71% | -7.69% |
| Operating Income | -22.94% | -26.46% | -28.21% | 125.06% | 3.71% |
| Income Before Tax | -19.15% | -70.84% | -51.92% | 169.92% | 9.34% |
| Income Tax Expenses | -35.46% | -127.22% | -24.99% | 208.68% | 79.62% |
| Earnings from Continuing Operations | -14.94% | -64.31% | -58.58% | 162.56% | -0.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -721.92% | -23,966.67% | 53.85% | -193.03% | -1,925.00% |
| Net Income | -15.61% | -66.90% | -58.59% | 160.61% | -0.80% |
| EBIT | -22.94% | -26.46% | -28.21% | 125.06% | 3.71% |
| EBITDA | -20.19% | -12.48% | -22.31% | 84.04% | -0.85% |
| EPS Basic | -15.14% | -66.42% | -56.62% | 175.66% | 4.71% |
| Normalized Basic EPS | -13.11% | -5.22% | -14.13% | 152.21% | 14.27% |
| EPS Diluted | -15.85% | -67.35% | -56.41% | 172.22% | 6.49% |
| Normalized Diluted EPS | -13.93% | -5.77% | -14.66% | 151.71% | 15.81% |
| Average Basic Shares Outstanding | -0.55% | -1.42% | -4.55% | -5.45% | -5.26% |
| Average Diluted Shares Outstanding | 0.40% | -0.80% | -3.96% | -5.27% | -6.51% |
| Dividend Per Share | 11.11% | 11.11% | 8.00% | 8.00% | 8.00% |
| Payout Ratio | 0.31% | 2.22% | 1.48% | -0.61% | 0.03% |